Press releases

Atrogi announces Cell paper highlighting transformative potential of muscle-targeted therapy in metabolic disease

Atrogi Announces Publication on Advancements in Combatting Obesity and Metabolic Complications

Atrogi Announces Positive Clinical Data from First-in-Class Insulin-Independent Treatment for Type 2 Diabetes

Atrogi announces first patient treated with Adrenoceptor agonist

Anders Ekblom as new chairman of the board

Atrogi receives Eurostars grant to develop obesity project

Atrogi has completed a SEK 90 million rights issue